Ponsus Pharma attending EADV

Published on Tuesday, 10 August 2010 00:00

Ponsus Pharma will be attending 19th Congress of the European Academy of Dermatology and Venereology in Gothenburg 6-10th of October

STOCKHOLM, Aug. 10. Ponsus Pharma will be attending the EADV in October and is looking for out-licensing products based on its Proderm Technology. Ponsus Pharma AB develops high performing dermatological products based on their patented Proderm Technology for companies, targeting the dermatological market. The water-lipid nature of the Proderm Technology allows ingredients to be rapidly absorbed and incorporated into the outer layers of the skin. Furthermore, Proderm Technology is non-comedogenic and provides a cosmetically elegant feel in addition to ease of application because it is non-greasy and spreads easily. Unlike some topical foam preparations, Proderm Technology does not use either alcohol or other organic solvents, therefore it is well tolerated by patients. Ponsus Pharma markets their products mainly through a group of marketing partners in various countries.

For further information contact:
Lars Blak at: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Phone +46 8 511 88840
Fax +46 8 511 88841